J. Nougayrède, F. Taieb, J. De-rycke, and E. Oswald, Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle, Trends Microbiol, vol.13, pp.103-110, 2005.

J. Nougayrède, S. Homburg, F. Taieb, M. Boury, E. Brzuszkiewicz et al., Escherichia coli induces DNA double-strand breaks in eukaryotic cells, Science, vol.313, pp.848-851, 2006.

G. Cuevas-ramos, C. R. Petit, I. Marcq, M. Boury, E. Oswald et al., Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells, Proc. Natl. Acad. Sci, vol.107, pp.11537-11542, 2010.

D. Dubois, J. Delmas, A. Cady, F. Robin, A. Sivignon et al., Cyclomodulins in urosepsis strains of Escherichia coli, J. Clin. Microbiol, vol.48, pp.2122-2129, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01931345

J. R. Johnson, B. Johnston, M. A. Kuskowski, J. Nougayrede, and E. Oswald, Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island, J. Clin. Microbiol, vol.46, pp.3906-3911, 2008.

J. Putze, C. Hennequin, J. Nougayrède, W. Zhang, S. Homburg et al., Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae, Infect. Immun, vol.77, pp.4696-4703, 2009.

F. L. Nowrouzian and E. Oswald, Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island, Microb. Pathog, vol.53, pp.180-182, 2012.

D. Payros, T. Secher, M. Boury, C. Brehin, S. Ménard et al., Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis, Gut Microbes, vol.5, pp.313-325, 2014.
DOI : 10.4161/gmic.28932

URL : https://www.tandfonline.com/doi/pdf/10.4161/gmic.28932?needAccess=true

L. Micenková, A. B?-nová, L. Frankovi?ová, J. Bosák, M. Vrba et al.,

, Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions, Int. J. Med. Microbiol, vol.307, pp.182-189, 2017.

A. J. Mccarthy, P. Martin, E. Cloup, R. A. Stabler, E. Oswald et al., The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection, Infect. Immun, vol.83, pp.3704-3711, 2015.

J. N. Krieger, U. Dobrindt, D. E. Riley, and E. Oswald, Acute Escherichia coli prostatitis in previously health young men: bacterial virulence factors, antimicrobial resistance, and clinical outcomes, Urology, vol.77, pp.1420-1425, 2011.
DOI : 10.1016/j.urology.2010.12.059

E. Buc, D. Dubois, P. Sauvanet, J. Raisch, J. Delmas et al., High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer, PLoS ONE, vol.8, 2013.

V. Eklöf, A. Löfgren-burström, C. Zingmark, S. Edin, P. Larsson et al., Cancer-associated fecal microbial markers in colorectal cancer detection, Int. J. Cancer, 2017.

J. C. Arthur, E. Perez-chanona, M. Mühlbauer, S. Tomkovich, J. M. Uronis et al., Intestinal inflammation targets cancer-inducing activity of the microbiota, Science, vol.338, pp.120-123, 2012.

M. Prorok-hamon, M. K. Friswell, A. Alswied, C. L. Roberts, F. Song et al., Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer, Gut, vol.63, pp.761-770, 2014.
DOI : 10.1136/gutjnl-2013-304739

URL : https://gut.bmj.com/content/63/5/761.full.pdf

M. Bonnet, E. Buc, P. Sauvanet, C. Darcha, D. Dubois et al., Colonization of the human gut by E. coli and colorectal cancer risk, Clin. Cancer Res, vol.20, pp.859-867, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02010933

A. Cougnoux, G. Dalmasso, R. Martinez, E. Buc, J. Delmas et al., Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype, Gut, vol.63, pp.1932-1942, 2014.
DOI : 10.1136/gutjnl-2013-305257

URL : https://hal.archives-ouvertes.fr/hal-01101227

S. Tomkovich, Y. Yang, K. Winglee, J. Gauthier, M. Mühlbauer et al., Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis, Cancer Res, vol.77, pp.2620-2632, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01607272

M. A. Fischbach and C. T. Walsh, Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms, Chem. Rev, vol.106, pp.3468-3496, 2006.
DOI : 10.1002/chin.200644265

M. Olier, I. Marcq, C. Salvador-cartier, T. Secher, U. Dobrindt et al., Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity, Gut Microbes, vol.3, pp.501-509, 2012.

T. Faïs, A. Cougnoux, G. Dalmasso, F. Laurent, J. Delmas et al., Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus, Antimicrob. Agents Chemother, vol.60, pp.6986-6988, 2016.

M. I. Vizcaino, P. Engel, E. Trautman, and J. M. Crawford, Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules, J. Am. Chem. Soc, vol.136, pp.9244-9247, 2014.
DOI : 10.1021/ja503450q

URL : https://doi.org/10.1021/ja503450q

T. Pérez-berezo, J. Pujo, P. Martin, P. Le-faouder, J. Galano et al., Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle, Nat. Commun, vol.8, 1314.

A. L. Flores-mireles, J. N. Walker, M. Caparon, and S. J. Hultgren, Urinary tract infections: epidemiology, mechanisms of infection and treatment options, Nat. Rev. Microbiol, vol.13, pp.269-284, 2015.

L. D. Sarff, G. H. Mccracken, M. S. Schiffer, M. P. Glode, J. B. Robbins et al., Epidemiology of Escherichia coli K1 in healthy and diseased newborns, Lancet, vol.1, pp.1099-1104, 1975.

O. Clermont, J. K. Christenson, E. Denamur, and D. M. Gordon, The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups, Environ. Microbiol. Rep, vol.5, pp.58-65, 2013.

P. Escobar-páramo, O. Clermont, A. Blanc-potard, H. Bui, C. Le-bouguénec et al., A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli, Mol. Biol. Evol, vol.21, pp.1085-1094, 2004.

J. Raisch, E. Buc, M. Bonnet, P. Sauvanet, E. Vazeille et al., Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation, World J. Gastroenterol, vol.20, pp.6560-6572, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01211998

O. Tenaillon, D. Skurnik, B. Picard, and E. Denamur, The population genetics of commensal Escherichia coli, Nat. Rev. Microbiol, vol.8, pp.207-217, 2010.

Y. Lai, A. Lin, M. Chiang, Y. Dai, C. Hsu et al., Genotoxic Klebsiella pneumoniae in Taiwan, PLoS ONE, vol.9, 2014.

C. P. Fung, B. S. Hu, F. Y. Chang, S. C. Lee, B. I. Kuo et al., A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy, J. Infect. Dis, vol.181, pp.2075-2079, 2000.

W. Thompson, L. Romance, H. Bialkowska-hobrazanska, R. P. Rennie, F. Ashton et al., Klebsiella pneumoniae infection on a rehabilitation unit: comparison of epidemiologic typing methods, Infect. Control Hosp. Epidemiol, vol.14, pp.203-210, 1993.

Y. Chen, Y. Lai, M. Tan, L. Hsieh, J. Wang et al., Prevalence and characteristics of pks genotoxin gene cluster-positive clinical Klebsiella pneumoniae isolates in Taiwan

X. Bian, J. Fu, A. Plaza, J. Herrmann, D. Pistorius et al., In vivo evidence for a prodrug activation mechanism during colibactin maturation, Chembiochem, vol.14, pp.1194-1197, 2013.

C. A. Brotherton and E. P. Balskus, A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity, J. Am. Chem. Soc, vol.135, pp.3359-3362, 2013.

P. Martin, I. Marcq, G. Magistro, M. Penary, C. Garcie et al., Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli, PLoS Pathog, vol.9, 2013.

L. Zha, M. R. Wilson, C. A. Brotherton, and E. P. Balskus, Characterization of Polyketide Synthase Machinery from the pks Island Facilitates Isolation of a Candidate Precolibactin, ACS Chem. Biol, vol.11, pp.1287-1295, 2016.

L. Zha, Y. Jiang, M. T. Henke, M. R. Wilson, J. X. Wang et al., Colibactin assembly line enzymes use S-adenosylmethionine to build a cyclopropane ring, Nat. Chem. Biol, 2017.

E. P. Trautman, A. R. Healy, E. E. Shine, S. B. Herzon, and J. M. Crawford, Domain-Targeted Metabolomics Delineates the Heterocycle Assembly Steps of Colibactin Biosynthesis, J. Am. Chem. Soc, vol.139, pp.4195-4201, 2017.

A. R. Healy, M. I. Vizcaino, J. M. Crawford, and S. B. Herzon, Convergent and Modular Synthesis of Candidate Precolibactins. Structural Revision of Precolibactin A, J. Am. Chem. Soc, vol.138, pp.5426-5432, 2016.

A. O. Brachmann, C. Garcie, V. Wu, P. Martin, R. Ueoka et al., Colibactin biosynthesis and biological activity depend on the rare aminomalonyl polyketide precursor, Chem. Commun. (Camb.), vol.51, pp.13138-13141, 2015.

Z. Li, J. Li, J. Gu, J. Y. Lai, B. M. Duggan et al., Divergent biosynthesis yields a cytotoxic aminomalonate-containing precolibactin, Nat. Chem. Biol, vol.12, pp.773-775, 2016.

M. I. Vizcaino and J. M. Crawford, The colibactin warhead crosslinks DNA, Nat. Chem, vol.7, pp.411-417, 2015.

N. S. Guntaka, A. R. Healy, J. M. Crawford, S. B. Herzon, and S. D. Bruner, Structure and Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway, ACS Chem. Biol, 2017.

J. J. Mousa, Y. Yang, S. Tomkovich, A. Shima, R. C. Newsome et al., MATE transport of the E. coli-derived genotoxin colibactin, Nat. Microbiol, 2016.

Z. Li, Y. Li, J. Y. Lai, J. Tang, B. Wang et al., Critical Intermediates Reveal New Biosynthetic Events in the Enigmatic Colibactin Pathway. Chembiochem, vol.16, pp.1715-1719, 2015.

A. Cougnoux, L. Gibold, F. Robin, D. Dubois, N. Pradel et al., Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP, J. Mol. Biol, vol.424, pp.203-214, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00748966

D. Dubois, O. Baron, A. Cougnoux, J. Delmas, N. Pradel et al., ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides, J. Biol. Chem, vol.286, pp.35562-35570, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00748957

N. Bossuet-greif, D. Dubois, C. Petit, S. Tronnet, P. Martin et al., Escherichia coli ClbS is a colibactin resistance protein. Mol. Microbiol, vol.99, pp.897-908, 2016.

P. Tripathi, E. E. Shine, A. R. Healy, C. S. Kim, S. B. Herzon et al., ClbS is a cyclopropane hydrolase that confers colibactin resistance, J. Am. Chem. Soc, 2017.
DOI : 10.1021/jacs.7b09971

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202678

X. Bian, A. Plaza, Y. Zhang, and R. Müller, Two more pieces of the colibactin genotoxin puzzle from Escherichia coli show incorporation of an unusual 1-aminocyclopropanecarboxylic acid moiety, Chem. Sci, vol.6, pp.3154-3160, 2015.

C. A. Brotherton, M. Wilson, G. Byrd, and E. P. Balskus, Isolation of a metabolite from the pks island provides insights into colibactin biosynthesis and activity, Org. Lett, vol.17, pp.1545-1548, 2015.

D. L. Boger and D. S. Johnson, CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents, Proc. Natl. Acad. Sci, vol.92, pp.3642-3649, 1995.

M. Tanasova and S. J. Sturla, Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents, Chem. Rev, vol.112, pp.3578-3610, 2012.
DOI : 10.1021/cr2001367

N. Bossuet-greif, J. Vignard, F. Taieb, G. Mirey, D. Dubois et al., The Colibactin Genotoxin Generates DNA Interstrand Cross-Links in Infected Cells, MBio, vol.9, 2018.
DOI : 10.1128/mbio.02393-17

URL : https://mbio.asm.org/content/mbio/9/2/e02393-17.full.pdf

A. J. Deans and S. C. West, DNA interstrand crosslink repair and cancer, Nat. Rev. Cancer, vol.11, pp.467-480, 2011.
DOI : 10.1038/nrc3088

URL : http://europepmc.org/articles/pmc3560328?pdf=render

R. S. Roy, A. M. Gehring, J. C. Milne, P. J. Belshaw, and C. T. Walsh, Thiazole and oxazole peptides: biosynthesis and molecular machinery, Nat. Prod. Rep, vol.16, pp.249-263, 1999.
DOI : 10.1039/a806930a

L. F. Povirk, M. Hogan, and N. Dattagupta, Binding of bleomycin to DNA: intercalation of the bithiazole rings, Biochemistry, vol.18, pp.96-101, 1979.

A. R. Healy, H. Nikolayevskiy, J. R. Patel, J. M. Crawford, and S. B. Herzon, A Mechanistic Model for Colibactin-Induced Genotoxicity, J. Am. Chem. Soc, vol.138, pp.15563-15570, 2016.
DOI : 10.1021/jacs.6b10354

URL : http://europepmc.org/articles/pmc5359767?pdf=render

S. Homburg, E. Oswald, J. Hacker, and U. Dobrindt, Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli, FEMS Microbiol. Lett, vol.275, pp.255-262, 2007.

S. Tronnet, C. Garcie, N. Rehm, U. Dobrindt, E. Oswald et al., Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin, Infect. Immun, vol.84, pp.3358-3368, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01605475

S. Tronnet, C. Garcie, A. O. Brachmann, J. Piel, E. Oswald et al., High iron supply inhibits the synthesis of the genotoxin colibactin by pathogenic Escherichia coli through a non-canonical Fur/RyhB-mediated pathway
URL : https://hal.archives-ouvertes.fr/hal-01603279

C. Garcie, S. Tronnet, A. Garénaux, A. J. Mccarthy, A. O. Brachmann et al., The Bacterial Stress-Responsive Hsp90 Chaperone (HtpG) Is Required for the Production of the Genotoxin Colibactin and the Siderophore Yersiniabactin in Escherichia coli, J. Infect. Dis, vol.214, pp.916-924, 2016.

V. Hancock, A. S. Seshasayee, D. W. Ussery, N. M. Luscombe, and P. Klemm, Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972, Mol. Genet. Genom, vol.279, pp.523-534, 2008.

J. C. Arthur, R. Z. Gharaibeh, M. Mühlbauer, E. Perez-chanona, J. M. Uronis et al., Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer, Nat. Commun, vol.5, 2014.

D. Payros, U. Dobrindt, P. Martin, T. Secher, A. P. Bracarense et al., The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota, vol.8, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01608529

A. Cougnoux, J. Delmas, L. Gibold, T. Faïs, C. Romagnoli et al., Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria, Gut, vol.65, pp.278-285, 2016.
DOI : 10.1136/gutjnl-2014-307241

C. Reuter, M. Alzheimer, H. Walles, and T. A. Oelschlaeger, An Adherent Mucus Layer Attenuates the Genotoxic Effect of Colibactin, Cell. Microbiol, 2017.

T. Secher, D. Payros, C. Brehin, M. Boury, C. Watrin et al., Oral tolerance failure upon neonatal gut colonization with Escherichia coli producing the genotoxin colibactin, Infect. Immun, vol.83, pp.2420-2429, 2015.
DOI : 10.1128/iai.00064-15

URL : https://iai.asm.org/content/83/6/2420.full.pdf

J. Gagnière, J. Raisch, J. Veziant, N. Barnich, R. Bonnet et al., Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol, vol.22, pp.501-518, 2016.

C. Lucas, N. Barnich, H. T. Nguyen, and . Microbiota, Inflammation and Colorectal Cancer, Int. J. Mol. Sci, vol.18, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02064680

J. Raisch, G. Dalmasso, R. Bonnet, N. Barnich, M. Bonnet et al.,

, Med. Sci, vol.32, pp.175-182, 2016.

J. Weitz, M. Koch, J. Debus, T. Höhler, P. R. Galle et al., Colorectal cancer. Lancet, vol.365, pp.153-165, 2005.

A. Swidsinski, M. Khilkin, D. Kerjaschki, S. Schreiber, M. Ortner et al., Association between intraepithelial Escherichia coli and colorectal cancer, Gastroenterology, vol.115, pp.281-286, 1998.
DOI : 10.1016/s0016-5085(98)70194-5

K. W. Kinzler, M. C. Nilbert, L. K. Su, B. Vogelstein, T. M. Bryan et al., Identification of FAP locus genes from chromosome 5q21, Science, vol.253, pp.661-665, 1991.

C. M. Dejea, P. Fathi, J. M. Craig, A. Boleij, R. Taddese et al., Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria, vol.359, pp.592-597, 2018.
DOI : 10.1126/science.aah3648

URL : http://science.sciencemag.org/content/sci/359/6375/592.full.pdf

T. Shimpoh, Y. Hirata, S. Ihara, N. Suzuki, H. Kinoshita et al., Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer, Gut Pathog, vol.9, 2017.

C. A. Lozupone, J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight, Diversity, stability and resilience of the human gut microbiota, Nature, vol.489, 2012.

H. Tjalsma, A. Boleij, J. R. Marchesi, and B. E. Dutilh, A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects, Nat. Rev. Microbiol, vol.10, pp.575-582, 2012.
DOI : 10.1038/nrmicro2819

J. Gagnière, V. Bonnin, A. Jarrousse, E. Cardamone, A. Agus et al., Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer, Clin. Sci, vol.131, pp.471-485, 2017.

T. Secher, A. Samba-louaka, E. Oswald, and J. Nougayrède, Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells, PLoS ONE, vol.8, 2013.
DOI : 10.1371/journal.pone.0077157

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0077157&type=printable

G. Dalmasso, A. Cougnoux, J. Delmas, A. Darfeuille-michaud, and R. Bonnet, The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment, Gut Microbes, vol.5, pp.675-680, 2014.
DOI : 10.4161/19490976.2014.969989

URL : http://europepmc.org/articles/pmc4615906?pdf=render

T. Faïs, J. Delmas, A. Cougnoux, G. Dalmasso, and R. Bonnet, Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments, Gut Microbes, vol.7, pp.329-333, 2016.

I. Marcq, P. Martin, D. Payros, G. Cuevas-ramos, M. Boury et al., The genotoxin colibactin exacerbates lymphopenia and decreases survival rate in mice infected with septicemic Escherichia coli, J. Infect. Dis, vol.210, pp.285-294, 2014.

M. Lu, Y. Chen, M. Chiang, Y. Wang, P. Hsiao et al., Colibactin Contributes to the Hypervirulence of pks(+) K1 CC23 Klebsiella pneumoniae in Mouse Meningitis Infections, Front. Cell. Infect. Microbiol, vol.7, p.103, 2017.

T. M. Wassenaar, Insights from 100 Years of Research with Probiotic E. coli, Eur. J. Microbiol. Immunol. (Bp), vol.6, pp.147-161, 2016.